Cargando…
A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma
BACKGROUND: With the improved knowledge of disease biology and the introduction of immune checkpoints, there has been significant progress in treating renal cell carcinoma (RCC) patients. Individual treatment will differ according to risk stratification. As the clinical course varies in RCC, it has...
Autores principales: | Xu, Chen, Zeng, Hui, Fan, Junli, Huang, Wenjie, Yu, Xiaosi, Li, Shiqi, Wang, Fubing, Long, Xinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918330/ https://www.ncbi.nlm.nih.gov/pubmed/35279104 http://dx.doi.org/10.1186/s12885-022-09322-9 |
Ejemplares similares
-
Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer
por: Xu, Jingxuan, et al.
Publicado: (2021) -
Integrated Analysis Identifies a Nine-microRNA Signature Biomarker for Diagnosis and Prognosis in Colorectal Cancer
por: Di, Ziyang, et al.
Publicado: (2020) -
Differential microRNA expression in renal cell carcinoma
por: CHENG, TINGTING, et al.
Publicado: (2013) -
MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis
por: Huang, Xiao-Ying, et al.
Publicado: (2013) -
MicroRNA expression profiles predict clinical phenotypes and prognosis in chromophobe renal cell carcinoma
por: Ge, Yu-Zheng, et al.
Publicado: (2015)